- Economy
- Education And Career
- Companies & Markets
- Gadgets & Technology
- After Hours
- Healthcare
- Banking & Finance
- Entrepreneurship
- Energy & Infra
- Case Study
- Video
- More
- Sustainability
- Web Exclusive
- Opinion
- Luxury
- Legal
- Property Review
- Cloud
- Blockchain
- Workplace
- Collaboration
- Developer
- Digital India
- Infrastructure
- Work Life Balance
- Test category by sumit
- Sports
- National
- World
- Entertainment
- Lifestyle
- Science
- Health
- Tech
Latest Articles in World Health Organisation WHO
WHO Calls For Immediate Action After Cough Syrup Deaths
In 2022, more than 300 children mainly aged under 5 - in Gambia, Indonesia and Uzbekistan died of acute kidney injury, in deaths that were associated with contaminated medicines, the WHO said in a statement on Monday
Read MoreAcute Malnutrition Threatens Lives Of Millions Of Vulnerable Children: WHO
United Nations agencies are calling for urgent action to protect the most vulnerable children in the 15 countries hardest hit by an unprecedented food and nutrition crisis
Read MoreCandidates Arrive In Uganda For Trials Of Ebola Vaccine
There are currently no licensed vaccines for the Sudan strain of the virus that caused the infections in Uganda, although there are several candidate vaccines that appear to be suitable for evaluation, the World Health Organization says
Read MoreOral Health Neglect Affecting Nearly Half Of World’s Population: WHO Report
The report shows that almost half of the world’s population (45 per cent or 3.5 billion people) suffer from oral diseases, with 3 out of every 4 affected people living in low- and middle-income countries
Read MoreLimited Vaccine Supply, Unequal Distribution Driving Global Disparities: WHO
The human papillomavirus (HPV) vaccine against cervical cancer has only been introduced in 41 per cent of low-income countries, even though they represent much of the disease burden, compared to 83 per cent of high-income countries, WHO said in a statement
Read More500 Mn People Will Develop Heart Diseases Due To Inactivity: WHO
Data from 194 countries show that overall, progress is slow and that countries need to accelerate the development and implementation of policies to increase levels of physical activity and thereby prevent disease and reduce burden on already overwhelmed health care systems
Read MoreWHO Approval To Covaxin Will Improve Ease Of Travel For Vaccinated Indians: MEA
MEA Spokesperson Arindam Bagchi said 96 countries have either accepted WHO-approved vaccines, which would include both Covishield and Covaxin, or in some cases only Covishield or Covaxin.
Read More'We Trust Indian Industry, Bharat Biotech Submitting Data Regularly, Very Quickly': WHO Official On Covaxin EUL
Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April 19 for the vaccine's Emergency Use Listing (EUL).
Read MoreSupply Chains For Vaccine Raw Materials Must Be Kept Open: Sitharaman
Sitharaman highlighted the need of an international financial architecture to fight the COVID-19 pandemic across the globe and supported the need of new financial instruments to focus and press forward green initiatives.
Read MoreWHO's Technical Group To Meet On Oct 26 To Consider Emergency Use Listing Of Covaxin
The WHO experts are currently reviewing this information and if it addresses all questions raised, the WHO assessment will be finalised next week.
Read MoreWHO To Take Final Decision Next Week On Approval To Bharat Biotech's Covaxin
WHO experts are currently reviewing this info & if it addresses all questions raised, WHO assessment will be finalized next week, WHO said in a series of tweets.
Read MoreDecision On Bharat Biotech's Covaxin EUL In October: WHO
Submissions to WHO for prequalification or listing under the emergency use procedure are confidential. If a product submitted for assessment is found to meet the criteria for listing, the WHO will publish the results widely.
Read MoreThe Latest: WHO Endorses Antibody Treatment For Some People
The UN health agency said the new advice was based on evidence from experimental trials, including a British-run study that is the world''s largest for testing potential COVID-19 treatments.
Read MoreWHO Recommends Antibody Treatment For Critical Covid Patients
The trial shows that casirivimab and imdevimab may reduce the risk of hospitalisation and duration of symptoms in those at the highest risk of severe diseases, such as unvaccinated, older, or immunosuppressed patients.
Read MoreIndia's Decision To Resume Covid-19 Vaccine Shipments Important Development: WHO Chief
India stopped the export of COVID-19 vaccines after the second wave of the pandemic hit the country in April this year.
Read More